Complexed PSA improves prostate cancer detection: Results from a multicenter Japanese clinical trial
- 1 February 2006
- Vol. 67 (2) , 328-332
- https://doi.org/10.1016/j.urology.2005.08.028
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Can Complexed Prostate Specific Antigen Enhance Prostate Cancer Detection in Japanese Men?European Urology, 2004
- Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6–4.0 ng/mL range of total PSABJU International, 2004
- Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptomsUrology, 2004
- Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical TrialJournal of Urology, 2003
- Complexed PSA performance for prostate cancer detection in an African-American populationUrology, 2003
- Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialUrology, 2002
- Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterUrology, 2002
- Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Urology, 2002
- CAN COMPLEXED PROSTATE SPECIFIC ANTIGEN AND PROSTATIC VOLUME ENHANCE PROSTATE CANCER DETECTION IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.Journal of Urology, 2001
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000